Waverley Pharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4-1250 Waverley St, Winnipeg, Manitoba, ...Phone Number
(204) 928-7907Website
www.waverleypharma.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Waverley Pharma
Waverley Pharma is an emerging pharmaceutical company focused on the development and commercialization of safe, effective, and affordable cancer therapeutics in the EU, United Kingdom and North American market. The Company, through its subsidiary, is currently selling three generic oncology products in the United Kingdom, namely capecitabine, temozolomide and erlotinib. In addition, the Company is developing two generic oncology products in Europe, namely pemetrexed and bortezomib and additional products in the United States. Waverley Pharma is committed to providing patients with affordable prescription medicines that lower healthcare costs and provide a better quality of life.Explore more
Waverley Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Waverley Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Waverley Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Waverley Pharma is spiking on competitors!
Click to see if Waverley Pharma had a recent Job posting/layoffs
Product Launch: Get notified when Waverley Pharma launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Waverley Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Waverley Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Waverley Pharma
Funding: Get notified immidiatlly once Waverley Pharma has new funding data
Recommended Actions
Find VP level buyers at Waverley Pharma
Find more new buyers
Compare Similar Companies to Waverley Pharma
Compare insights from companies similar to Waverley Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Waverley Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Waverley Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Waverley Pharma.
Waverley Pharma Tech Stack
A closer look at the technologies used by Waverley Pharma
Waverley Pharma News & Media
Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and ...
/CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the "Company") (TSXV: WAVE), an emerging Canadian pharmaceutical company, is pleased to announce that its...
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Waverley Pharma
Sign Up For FreeTo access detailed company insights
Waverley Pharma is an emerging pharmaceutical company focused on the development and commercialization of safe, effective, and affordable cancer therapeutics in the EU, United Kingdom and North American market. The Company, through its subsidiary, is currently selling three generic oncology products in the United Kingdom, namely capecitabine, temoz... Read More
